Skip to main content

Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.

Publication ,  Journal Article
Lamoth, F; Damonti, L; Alexander, BD
Published in: J Clin Microbiol
June 2016

No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMIs). In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most important predictor of therapeutic response. For amphotericin B, an MIC of ≤0.5 μg/ml was significantly associated with better 6-week outcomes.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Microbiol

DOI

EISSN

1098-660X

Publication Date

June 2016

Volume

54

Issue

6

Start / End Page

1638 / 1640

Location

United States

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Retrospective Studies
  • Prognosis
  • Middle Aged
  • Microbiology
  • Microbial Sensitivity Tests
  • Male
  • Invasive Fungal Infections
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lamoth, F., Damonti, L., & Alexander, B. D. (2016). Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections. J Clin Microbiol, 54(6), 1638–1640. https://doi.org/10.1128/JCM.00318-16
Lamoth, Frédéric, Lauro Damonti, and Barbara D. Alexander. “Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.J Clin Microbiol 54, no. 6 (June 2016): 1638–40. https://doi.org/10.1128/JCM.00318-16.
Lamoth F, Damonti L, Alexander BD. Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections. J Clin Microbiol. 2016 Jun;54(6):1638–40.
Lamoth, Frédéric, et al. “Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.J Clin Microbiol, vol. 54, no. 6, June 2016, pp. 1638–40. Pubmed, doi:10.1128/JCM.00318-16.
Lamoth F, Damonti L, Alexander BD. Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections. J Clin Microbiol. 2016 Jun;54(6):1638–1640.

Published In

J Clin Microbiol

DOI

EISSN

1098-660X

Publication Date

June 2016

Volume

54

Issue

6

Start / End Page

1638 / 1640

Location

United States

Related Subject Headings

  • Young Adult
  • Treatment Outcome
  • Retrospective Studies
  • Prognosis
  • Middle Aged
  • Microbiology
  • Microbial Sensitivity Tests
  • Male
  • Invasive Fungal Infections
  • Humans